HAS2 and familial pancreatic carcinoma: The diagnostic ROC analysis of SPHK1 and HAS2 in TCGA cohort showed that SPHK1 and HAS2 can serve as potential diagnostic biomarkers for pancreatic cancer (P < 0.05).